Results 101 to 110 of about 2,461 (207)

Fluorimetric quantification of brimonidine tartrate in eye drops.

open access: greenIndian J Pharm Sci, 2013
Sunitha G   +5 more
europepmc   +2 more sources

Cutaneous rosacea: a thorough overview of pathogenesis, clinical presentations, and current recommendations on management [PDF]

open access: yes, 2016
The review summarizes and systemizes available international data on the pathogenesis, clinical manifestations and current recommendations for the management of rosacea ...
Del Rosso J.Q.
core   +2 more sources

Rescue vitrectomy with blocked artery massage and bloodletting for branch retinal artery occlusion

open access: yesIndian Journal of Ophthalmology, 2017
A 61-year-old male suffered from sudden blurred vision and superior visual field defect oculus dexter. His vision was counting fingers at 20 cm. Fundoscopy demonstrated inferior pale retina and a large embolus located at the proximal inferior retinal ...
Chun-Ju Lin   +5 more
doaj   +1 more source

Facial Erythema of Rosacea - Aetiology, Different Pathophysiologies and Treatment Options [PDF]

open access: yes, 2016
Rosacea is a common chronic skin condition that displays a broad diversity of clinical manifestations. Although the pathophysiological mechanisms of the 4 subtypes are not completely elucidated, the key elements often present are augmented immune ...
Schauber, Jürgen   +2 more
core   +1 more source

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

open access: yesPatient Preference and Adherence, 2017
Michael S Anderson,1 Anish Nadkarni,1 Leah A Cardwell,1 Hossein Alinia,1 Steven R Feldman1–3 1Department of Dermatology, Center for Dermatology Research, 2Department of Pathology, 3Department of Public Health Sciences, Wake Forest School of ...
Anderson MS   +4 more
doaj  

DESIGN AND EVALUATION OF CONTROLLED-RELEASE OCULAR INSERTS OF BRIMONIDINE-TARTRATE AND TIMOLOL MALEATE [PDF]

open access: yes, 2017
Objective: The current work was attempted to formulate and evaluate a controlled-release matrix-type ocular inserts containing a combination of brimonidine tartrate and timolol maleate, with a view to sustain the drug release in the cul-de-sac of the eye.
B., Preethi G., Kunal, Prashanth
core   +1 more source

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

open access: yesClinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Effect of brimonidine on anterior-chamber angle in patients with narrow angles

open access: yesPhilippine Journal of Ophthalmology, 2011
Objective: This study investigated the effect of brimonidine on the anterior-chamber angle in eyes with narrow angles using noncontact three-dimensional anterior-segment analyzer Pentacam.
Johanna Timoteo-Cervantes, MD   +2 more
doaj  

Home - About - Disclaimer - Privacy